Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology*; D002772:Cholera Toxin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004768:Enterotoxins / Q000494:pharmacology; D004926:Escherichia coli; D005260:Female; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D007421:Intestine, Small / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011458:Prostaglandins E / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism
D004768:Enterotoxins; D011458:Prostaglandins E; D003994:Bucladesine; D002772:Cholera Toxin; D011494:Protein Kinases; D000262:Adenylyl Cyclases; D002746:Chlorpromazine